| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $448.7M | +1.5% |
| Cost of Revenue | $331.2M | +0.2% |
| Gross Profit | $117.5M | +5.4% |
| R&D Expense | $16.9M | -1.7% |
| SG&A Expense | $36.2M | +0.0% |
| Operating Income | $50.2M | +4.6% |
| Interest Expense | $12.5M | +363.0% |
| Pre-tax Income | $85.9M | +17.7% |
| Income Tax | $8.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.96B | +191.5% |
| Accounts Receivable | $30.7M | -61.6% |
| Inventory | $322.9M | +99.8% |
| Current Assets | $2.36B | +132.8% |
| Total Assets | $2.45B | +123.7% |
| Current Liabilities | $422.8M | +21.9% |
| Long-term Debt | $1.17B | +148.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $51.0M | +37.8% |
| Capital Expenditures | $19.7M | +380.5% |
| Investing Cash Flow | -$19.7M | -380.5% |
| Financing Cash Flow | $1.22B | +180.2% |
| Free Cash Flow | $31.3M | -4.9% |
| +4150.0% |
| Net Income | $77.8M | +6.3% |
| EPS (Basic) | $4.33 | -3.6% |
| EPS (Diluted) | $3.90 | -12.8% |
| Total Liabilities |
| $1.68B |
| +80.3% |
| Stockholders' Equity | $765.1M | +374.0% |